Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Margetuximab-cmkb injection is used to treat metastatic (cancer that has spread) HER2-positive breast cancer in patients who have received two or more anti-HER2 breast cancer treatments, and at least one treatment for metastatic disease.
Margetuximab-cmkb is a monoclonal antibody that changes the immune system to help control the growth of cancer cells.
This medicine is to be given only by or under the direct supervision of your doctor.